Raily Aesthetic Medicine International Holdings Limited (2135.HK) Stock

About Raily Aesthetic Medicine International Holdings Limited

Raily Aesthetic Medicine International Holdings Limited, an investment holding company, provides aesthetic medical services in the People's Republic of China. It operates through Aesthetic Medical Services, Consulting Services, and Aesthetic Medical Equipment Products segments. The company provides aesthetic surgery services, including aesthetic surgery services comprising aesthetic surgical procedures performed on various parts of the face or body; minimally invasive aesthetic services, such as aesthetic injection procedures; aesthetic dermatology services that consists of various aesthetic energy-based procedures and photoelectric items; aesthetic dental services that include orthodontics, dental implant, and dental whitening; and aesthetic medical management consulting services. It also offers aesthetic medical equipment products comprising collagen injection products, surgical implants, and aesthetic medical skincare products. In addition, the company owns and operates a network of private for-profit aesthetic medical institutions; and trades in medical equipment. It serves individual retail clients and aesthetic medical institutions. Raily Aesthetic Medicine International Holdings Limited was founded in 2008 and is headquartered in Hangzhou, the People's Republic of China. The company operates as a subsidiary of Ruide Consultation Limited.

Raily Aesthetic Medicine International Holdings Limited is led by CEO Jianliang Song, employs 264 people, headquartered in Hangzhou, CN, publicly traded since 2020.

Raily Aesthetic Medicine International Holdings Limited (2135.HK) stock trades at $0.12 with a market capitalization of $65.74M. The stock is valued at price-to-book of 0.52, price-to-sales of 0.35. Over the past 52 weeks the stock has ranged between $0.09 and $0.20, and currently trades 40.0% below its 52-week high.

On profitability, Raily Aesthetic Medicine International Holdings Limited generates a return on equity (ROE) of -2.27%, an operating margin of 12.17%, a net profit margin of 0.99%.

Official website: www.raily.com